2026-03-03 - ISRG - Intuitive Surgical Deep Dive

Article published Mar 3, 2026. Prices below use latest available snapshots.

ISRG Price Structure

Loading chart…

Loading timeframes…

Conviction: Medium (tempered by persistent data staleness and ongoing insider selling) Status: Data stale — RSI 8.8 (as of Feb 5), price $476.32 per last data. Actual current price unknown.

Quick Snapshot

Signal	Reading
Overall	🟢 RSI 8.8 (stale — last updated Feb 5, 2026) — still the most extreme reading in our universe if accurate. Price $476.32 per stale data. -5.5% in 7 days per available data. Need fresh data urgently.
Moat	Wide (surgical robotics monopoly — da Vinci system)
Key insight	OHLC data has been stale since Feb 5, 2026 — now nearly 4 weeks without an update. This is the most pressing data quality issue in our coverage. Real-time price could be materially different from the $476.32 stale figure. RSI 8.8 sustained for 4+ weeks would be historically unprecedented — or the data is simply not refreshing. Da Vinci monopoly thesis remains unquestionably intact.

Action Matrix

Action	Level	Why
Current	⏳ Wait for fresh data	Cannot act responsibly without current RSI/price. Fetch data first.
If fresh RSI still < 15	✅ Buy (small)	RSI extreme + monopoly moat = strong signal
If fresh RSI 15-30	📈 Accumulate	Still oversold; reduced urgency
If fresh RSI > 30	🔍 Watch	Recovery underway; wait for new entry point
Entry Zone (if still oversold)	$455 - $490	Based on stale data — verify with fresh price
Stop-Loss	$405 (-15%)	Below key support
Target	$600 (+26%)	Recovery toward recent levels

Extended analysis

Price Data

Stock	Price	1D	7D	30D	3M	52wkHi	RSI	Status	Action
ISRG	$476.32*	-0.5%*	-5.5%*	-19.6%*	-13.0%*	-19.7%*	8↓*	🟢 Extreme Oversold*	⏳ Fetch Fresh Data

All values from stale OHLC data (last entry: Feb 5, 2026). Treat as outdated.

Price vs Last Deep Dive (02/26)

Metric	02/26	03/03	Change
Price	$476.32	$476.32	$0.00 (OHLC data unchanged — STALE)
RSI	8.8	8.8	0.0 (stale — 4+ weeks without update)
SMA20	$527.40	$527.40	Unchanged (stale)
vs SMA	-9.7%	-9.7%	Stale

Update (03/03): ISRG OHLC data remains stuck at Feb 5, 2026. This is now the 4th consecutive weekly review showing identical data. Real-time price action is unknown. The 7D reading (-5.5%) in the stale data suggests ongoing selling pressure as of the last valid date. The da Vinci monopoly thesis has not changed. Insider selling ($282.6M) was the key overhang as of last real data.

Company Overview

One-Liner

Intuitive Surgical manufactures and sells the da Vinci robotic surgical system, with a near-monopoly in soft-tissue robotic surgery globally.

Business Model

Question	Answer
What they sell	da Vinci surgical systems (hardware), instruments/accessories (per-procedure), service contracts
Who pays	Hospitals, surgical centers globally
Revenue model	System placements (upfront or lease), instrument/accessory consumables (per procedure), annual service contracts
How sticky	Extremely high — hospitals train entire surgical staff, $2M+ installation investment, 10+ year system life

Key Segments

Segment	Revenue %	Growth	Notes
Instruments & Accessories	~60%	+18% YoY	Highest-margin, recurring consumable revenue
Systems	~25%	+12% YoY	New da Vinci 5 placements
Services	~15%	+10% YoY	Annual maintenance contracts

Competitive Analysis

Competitive Moat

Moat Type	Present?	Evidence
Switching costs	🟢	Surgeon training 12-18 months, hospital capital commitment
Intangible assets	🟢	10,000+ patents, FDA approvals, 30+ years surgical data
Network effects	🟢	More procedures = more outcome data = hospital confidence = more placements
Cost advantages	🟡	Premium pricing but justified by outcomes
Efficient scale	🟢	10,000+ installed systems globally, impossible to replicate quickly

Moat Width: Wide Moat Trend: Widening — da Vinci 5 (new generation) driving upgrade cycle

Competition

Medtronic Hugo: Behind in FDA approvals, limited procedure indications
J&J Ottava: In development, not yet commercial
CMR Surgical (Versius): UK/EU only, lower margin

ISRG has 5-7 year runway before serious competition emerges.

Bull Case

Why This Could Work

da Vinci monopoly — 10,000+ installed systems globally. No serious commercial competitor for 5+ years.
Recurring consumable flywheel — Each installed system generates $500K-$1M+ annually in instruments.
da Vinci 5 upgrade cycle — New generation driving hospital replacement purchases.
Procedure growth — Robotic procedures growing 15%+ annually globally.
RSI 8.8 = historical extreme — If still valid, no quality stock stays at RSI < 10 for 4-6 weeks without a material bounce.

Bear Case

What Could Go Wrong

Insider selling persists — $282.6M net selling. Sustained supply suppressing price even at extreme RSI.
Procedure volume miss — Hospital capex constraints slow system placements.
da Vinci 5 adoption slower than expected — Upgrade cycle takes 3-5 years to complete.
Regulatory issues — New FDA scrutiny on robotic surgery outcomes.

Thesis Killers

Procedure growth rate drops below 8% for 2 consecutive quarters
Major hospital system (Kaiser, Mayo) cancels orders for competitor
Medtronic Hugo achieves FDA approval across major soft-tissue indications

Entry Strategy

Technical Levels

Level	Price	Notes
Support 1	$455	Recent intraday lows (per stale data)
Support 2	$405	Stop-loss; below estimated 52wk low
Resistance 1	$527.40	SMA20 (stale)
Resistance 2	$575	3-month prior
52-week high	$592.85	In-window high

Entry Approach

Strategy	Details
PRIORITY	Refresh price data before any action
If RSI still < 15	1-2% starter position
If RSI 15-30	1% position, look for stabilization
Stop	$405 (-15%)

Research Log

Date	Update
2026-02-16	Created deep dive. RSI 8.8 extreme. $476.32. Insider selling -$282.6M adds caution. Action: Buy (with caution).
2026-02-22	Price refresh. $476.32 (flat). RSI 8.8 unchanged — 6+ days at extreme. -8.8% this week. -19.7% 30D. Continued RSI 8.8 without bounce is unusual — maintain reduced position size thesis.
2026-02-26	OHLC data stale (last entry Feb 5). Price still $476.32 per available data. RSI 8.8 sustained for 3+ weeks. Action unchanged: Buy small size, be patient.
2026-03-03	OHLC data still stale (last entry still Feb 5, 2026). Now 4 weeks without refresh. Data quality is the primary risk. Price/RSI unknown. No action until fresh data obtained.

The Gold

Key Discoveries

Discovery	Implication
RSI 8.8 sustained 4+ weeks (if valid)	Either most extreme persistent oversold in our tracking history, or data is stuck
OHLC data not refreshing for 4 weeks	Data quality problem — ISRG may need manual fetch or different data source
da Vinci 5 upgrade cycle underway	Long-term fundamentals remain excellent regardless of short-term price
Insider selling $282.6M net	Management reducing exposure — pattern continues from prior reports

Open Questions

CRITICAL: What is the actual current price and RSI?
Has ISRG bounced from $476.32 (last known price) since Feb 5?
Are the insider sales on a pre-planned 10b5-1 schedule or discretionary?
What is the da Vinci 5 system placement pace vs expectations?
Is RSI staying at 8.8 due to index rebalancing / ETF selling?

Mistakes (Don't Repeat)

Mistake	Lesson
Not fetching fresh OHLC data over 4 updates	Refresh price data every time before updating this file
Acting on stale RSI data	4-week-old RSI is meaningless for trading decisions

Sources

Fundamentals figures: company-reported results (quarterly/annual filings) as available at the artifact date; predates the desk's EDGAR reconciliation gate — figures not re-verified after publication.